Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An updated patent review of p38 MAP kinase inhibitors (2014-2019)
Vanessa Haller, Philipp Nahidino, Michael Förster, et al.
Expert Opinion on Therapeutic Patents (2020) Vol. 30, Iss. 6, pp. 453-466
Closed Access | Times Cited: 72

Showing 1-25 of 72 citing articles:

Trends in kinase drug discovery: targets, indications and inhibitor design
Misty M. Attwood, Doriano Fabbro, Aleksandr V. Sokolov, et al.
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 11, pp. 839-861
Closed Access | Times Cited: 569
Diversity and versatility of p38 kinase signalling in health and disease
Begoña Cánovas, Ángel R. Nebreda
Nature Reviews Molecular Cell Biology (2021) Vol. 22, Iss. 5, pp. 346-366
Open Access | Times Cited: 424
Targeting MAPK signaling: A promising approach for treating inflammatory lung disease
Shakir Saleem
Pathology - Research and Practice (2024) Vol. 254, pp. 155122-155122
Closed Access | Times Cited: 15
The role of stress kinases in metabolic disease
Ivana Nikolić, Magdalena Leiva, Guadalupe Sabio
Nature Reviews Endocrinology (2020) Vol. 16, Iss. 12, pp. 697-716
Closed Access | Times Cited: 74
Where traditional Chinese medicine meets Western medicine in the prevention of rheumatoid arthritis
Per‐Johan Jakobsson, Luke P. Robertson, Janika Welzel, et al.
Journal of Internal Medicine (2022) Vol. 292, Iss. 5, pp. 745-763
Open Access | Times Cited: 38
Berberine inhibits RA-FLS cell proliferation and adhesion by regulating RAS/MAPK/FOXO/HIF-1 signal pathway in the treatment of rheumatoid arthritis
Zhiqi Li, Meilin Chen, Zhaoyi Wang, et al.
Bone and Joint Research (2023) Vol. 12, Iss. 2, pp. 91-102
Open Access | Times Cited: 30
Function and inhibition of P38 MAP kinase signaling: Targeting multiple inflammation diseases
Jiahui Wang, Yongjian Liu, Yushi Guo, et al.
Biochemical Pharmacology (2023) Vol. 220, pp. 115973-115973
Closed Access | Times Cited: 30
Nanoinformatics and nanotechnology in anti-inflammatory therapy: A review
Ashwini Kumar Mishra, Laxmi Rani, Rajesh Singh, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 93, pp. 105446-105446
Closed Access | Times Cited: 11
Nuclear P38: Roles in Physiological and Pathological Processes and Regulation of Nuclear Translocation
Galia Maik-Rachline, Lucia Lifshits, Rony Seger
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 17, pp. 6102-6102
Open Access | Times Cited: 51
Decisive role of water and protein dynamics in residence time of p38α MAP kinase inhibitors
Tatu Pantsar, Philipp D. Kaiser, Mark Kudolo, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 33
A New Pathway for the Preparation of Pyrano[2,3-c]pyrazoles and molecular Docking as Inhibitors of p38 MAP Kinase
Hai Truong Nguyen, Minh-Nhat Ha Truong, Tan Van Le, et al.
ACS Omega (2022) Vol. 7, Iss. 20, pp. 17432-17443
Open Access | Times Cited: 32
Exploring Small-Molecule Inhibitors Targeting MAPK Pathway Components: Focus on ERK, MEK1, and MEK2 Kinases in Cancer Treatment
Tuhin Mukherjee, Satyajit Mohanty, Jasleen Kaur, et al.
Chemical Biology Letters (2024) Vol. 11, Iss. 2, pp. 659-659
Open Access | Times Cited: 6
The functional role of p38 MAPK pathway in malignant brain tumors
Nathália Grave, Thamiris Becker Scheffel, Fernanda Fernandes Cruz, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 24
A patent review of MAPK inhibitors (2018 – present)
Valentin Wydra, Raphael Ditzinger, Nico J. Seidler, et al.
Expert Opinion on Therapeutic Patents (2023) Vol. 33, Iss. 6, pp. 421-444
Closed Access | Times Cited: 13
Discovery of a Novel p38α-MK2 Complex Inhibitor as a Potential Choice for Autoimmune Diseases
Ding-Wei Fu, Zimo Yang, Xiangyu Jia, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Binding mechanism of inhibitors to DFG-in and DFG-out P38α deciphered using multiple independent Gaussian accelerated molecular dynamics simulations and deep learning
Guohua Xu, Wei Zhang, Jinsong Du, et al.
SAR and QSAR in environmental research (2025), pp. 1-26
Closed Access
Development of Potent Type V MAPK Inhibitors: Design, Synthesis, and Biological Evaluation of Benzothiazole Derivatives Targeting p38α MAPK in Breast Cancer Cells
Bayan Zoatier, Kübra Gizem Yildiztekin, Mehmet Abdullah Alagöz, et al.
Archiv der Pharmazie (2025) Vol. 358, Iss. 4
Open Access
The PKR/P38/RIPK1 Signaling Pathway as a Therapeutic Target in Alzheimer’s Disease
Jacques Hugon, Claire Paquet
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 6, pp. 3136-3136
Open Access | Times Cited: 30
MRTF: Basic Biology and Role in Kidney Disease
Maria Zena Miranda, Zsuzsanna Lichner, Katalin Szászi, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 6040-6040
Open Access | Times Cited: 29
The Role of p38γ in Cancer: From review to outlook
Wentao Xu, Rui Liu, Ying Dai, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 14, pp. 4036-4046
Open Access | Times Cited: 28
p38 activation and viral infection
Luyao Wang, Zhiqiang Xia, Wei Tang, et al.
Expert Reviews in Molecular Medicine (2022) Vol. 24
Closed Access | Times Cited: 19
Synthesis and Biological Activity of a VHL-Based PROTAC Specific for p38α
Monica Cubillos‐Rojas, Guillem Loren, Yusuf Zaim Hakim, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 611-611
Open Access | Times Cited: 11
Mitogen-activated protein kinase-guided drug discovery for post-viral and related types of lung disease
Michael J. Holtzman, Yong Zhang, Kangyun Wu, et al.
European Respiratory Review (2024) Vol. 33, Iss. 171, pp. 230220-230220
Open Access | Times Cited: 4
The p38 MAPK Inhibitors and Their Role in Inflammatory Diseases
Thamires Rocco Machado, Thayná Rocco Machado, Pedro G. Pascutti
ChemistrySelect (2021) Vol. 6, Iss. 23, pp. 5729-5742
Closed Access | Times Cited: 26
Co-receptor signaling in the pathogenesis of neuroHIV
Emily Nickoloff-Bybel, Lindsay Festa, Olimpia Meucci, et al.
Retrovirology (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 25
Page 1 - Next Page

Scroll to top